Category Archives: Pr Newswire

Boehringer is expanding its global Computational Innovation footprint with a new center dedicated to AI and machine learning (ML) in the UK Establishing a presence in King’s Cross, London, places Boehringer at the heart of AI and life sciences innovation, providing access to world-class talent across academia, technology, and research ecosystems Ambition to advance AI […]

Patient screening to begin this month DURHAM, N.C., April 20, 2026 (GLOBE NEWSWIRE) — Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the independent Data Monitoring Committee (DMC) for the Phase 1/2/3 LIGHTHOUSE Trial evaluating ATSN-201 for the treatment […]

Updated AACR poster data show continued survival follow-up in heavily pre‑treated patients following a single intratumoral UNO injection Received US patent allowance covering proprietary gas delivery technology for UNO GARDEN CITY, N.Y., April 20, 2026 (GLOBE NEWSWIRE) — Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an investigational […]

Cancer survivor and wealth expert Helen Huang introduces a nurse-led regenerative health model focused on cellular restoration, immune optimization, and longevity. TORONTO, ON, April 20, 2026 (GLOBE NEWSWIRE) — Max Immunity Clinic, a premier health management practice specializing in cellular energy restoration and advanced regenerative therapies, is celebrating its grand opening on April 24 and […]

SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported a positive outcome in its formal clinical consultation with Japan’s Pharmaceutical and Medical Device Agency (PMDA). PMDA has determined that the clinical safety and efficacy evidence […]

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one owner Advancing felzartamab – a CD38-directed antibody with potential broad applicability across a range of immune-mediated conditions – in the Greater China Region presents an important opportunity in a key global market Agreement builds on TJ […]

SHANGHAI, April 20, 2026 /PRNewswire/ — Whale Cloud, a global leader in providing full-stack digital and intelligent capabilities for telecommunications and enterprise customers, and AGIBOT, a pioneer in general-purpose embodied robots, announced a strategic partnership to co-develop global embodied AI markets. The collaboration integrates AGIBOT’s robotics technology with Whale Cloud’s global reach and industry experience. The […]

HANNOVER, Germany, April 20, 2026 /PRNewswire/ — On April 20, Hannover Messe 2026 officially opened at the Exhibition Grounds Hannover in Germany. At Hall 27, Stand H11, Guide showcased its full portfolio of Thermography Tools and Integrated IoT solutions. The booth attracted a large number of professional visitors and industry experts from around the world […]

SHANGHAI, April 20, 2026 /PRNewswire/ — Covation Biomaterials LLC (“CovationBio®“), a biomaterials company with advanced technology in the bio-based materials industry, announced today that its first commercial plant for the C4 product platform, including bioTHF and bio-based polytetramethylene ether glycol (“PTMEG”), achieved mechanical completion in April 2026. In addition, CovationBio now officially launches the Xatryx® brand for the […]

KITCHENER, ON, April 20, 2026 /PRNewswire/ — Canadian Solar Inc. (“the Company”, “Canadian Solar”) (NASDAQ: CSIQ) today announced that it will hold a conference call on Thursday May 14, 2026, at 8:00 a.m. U.S. Eastern Time to discuss the Company’s first quarter 2026 results and business outlook. The dial-in phone number for the live audio […]